Step-by-step description of robot-assisted radical prostatectomy with the novel HUGO RAS robotic system using the Aalst-Technique

Paciotti, M.; Bravi, C.A.; Mottaran, A.; Nocera, L.; Sarchi, L.; Farinha, R.; Piro, A.; Lores, M. Peraire; Balestrazzi, E.; Piramide, F.; D’Hondt, F.; Naeyer, G. De; Groote, R. De; Mottrie, A.

doi:10.1016/s0302-2838(23)01427-6

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also, due to the expiration of the existing key patents for the Da Vinci ® robotic surgical system in 2019, new robotic platforms have been introduced into the market 1,14 . In this context, the HUGO™ RAS System has emerged as a viable option for robot‐assisted minimally invasive surgeries in adults 15,16 . Indeed, several studies have been recently published from different groups describing their preliminary experiences with the HUGO™ RAS system 12,17–20 .…”

Section: Discussionmentioning

confidence: 99%

“…1,14 In this context, the HUGO™ RAS System has emerged as a viable option for robot-assisted minimally invasive surgeries in adults. 15,16 Indeed, several studies have been recently published from different groups describing their preliminary experiences with the HUGO™ RAS system. 12,[17][18][19][20] Those reports showed the feasibility and safety of these platforms for urological, gynaecological and general surgical procedures.…”

Section: Overall (N = 38)mentioning

confidence: 99%

See 1 more Smart Citation

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

Collà Ruvolo,

Afonina,

Balestrazzi

et al. 2023

Robotics Computer Surgery

View full text Add to dashboard Cite

BackgroundWe aimed to compare the outcomes of Robot‐assisted sacrocolpopexy (RASC) performed using the novel HUGOTM Robot‐Assisted Surgery (RAS) System with the Da Vinci® Xi surgical system.MethodsData from 38 women undergoing RASC for a ≥ 2‐grade pelvic organ prolapse were collected (2021–2023).ResultsOverall, 23 (60.5%) and 15 (39.5%) procedures were performed using the DaVinci® Xi and the HUGOTM RAS system, respectively. The median total operative time was 123 (IQR:106.5–140.5) minutes for the DaVinci® Xi versus 120 (IQR:120–146) minutes for the HUGOTM RAS cases (p = 0.5). No conversion to open/laparoscopic surgery, perioperative complications, or system failures occurred. No differences were recorded according to day of catheter removal and length of stay.ConclusionsThis study represents the first worldwide comparison of RASC executed using the HUGOTM RAS versus the Da Vinci® Xi System. Our data suggest that RASC might be performed with both robotic platforms with similar perioperative outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Overall (N = 38)mentioning

confidence: 99%

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

Collà Ruvolo,

Afonina,

Balestrazzi

et al. 2023

Robotics Computer Surgery

View full text Add to dashboard Cite

show abstract

“…During this period the popularity and the development of robotic technologies for the treatment of prostate cancer has increased significantly; however, RARP service development has been limited by platform availability and cost- Original Article effectiveness issues [5]. The increasing competition from new robotic surgical platforms may further drive utilisation of the robotic approach [6,7].…”

Section: Introductionmentioning

confidence: 99%

Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies

De Maria,

Meneghetti,

Mosillo

et al. 2023

BJU International

View full text Add to dashboard Cite

ObjectiveTo present the results of the first series of patients treated with robot‐assisted radical prostatectomy (RARP) with the use of the Versius® Surgical System (CMR Surgical Ltd., Cambridge, UK). RARP has demonstrated better perioperative outcomes compared to open RP. However, RARP remains limited by platform availability and cost‐effectiveness issues. The increasing competition from new robotic surgical platforms may further drive utilisation of the robotic approach.Patients and MethodsData were collected prospectively for our first 18 consecutive patients with localised prostate cancer who underwent RARP at our centre over a 3‐month period. We recorded parameters, including patient demographics and perioperative outcomes. We also report our optimised set‐up with regard to trocar placement, bedside unit placement, and overall composition of the operating room for this procedure. Describing the incremental modifications carried out to achieve reductions in set‐up and operating times to optimise utilisation of the Versius system.ResultsThe median (interquartile range [IQR]) set‐up time was 8.5 (7–10) min. The median (IQR) console time was 201 (170–242) min. The median (IQR) operative time was 213 (186–266) min. The median (IQR) total surgery time was 226 (201–277) min. Bilateral pelvic lymphadenectomy median (IQR) time was 19 (17–20) min. There were no complications and/or limitations related to the use of the Versius system including need for conversion. There were no relevant intra‐ or postoperative complications at the 1‐month follow‐up related to the use of the Versius system. Patients were discharged after a median (IQR) of 4 (3.75–5) days, and the transurethral catheter was removed after a mean (range) of 8 (7–14) days. Continence at 2 months was achieved in 72.2% of the patients.ConclusionsPerforming RARP using the Versius system is feasible, safe, and easily reproducible. Our set‐up enables a rapid docking approach and efficient completion of the surgery.

show abstract

Step-by-step description of robot-assisted radical prostatectomy with the novel HUGO RAS robotic system using the Aalst-Technique

Cited by 2 publications

References 0 publications

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies

Contact Info

Product

Resources

About

Step-by-step description of robot-assisted radical prostatectomy with the novel HUGO RAS robotic system using the Aalst-Technique

Cited by 2 publications

References 0 publications

A comparative analysis of the HUGOTM robot‐assisted surgery system and the Da Vinci® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

A comparative analysis of the HUGOTM robot‐assisted surgery system and the Da Vinci® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies

Contact Info

Product

Resources

About

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment

A comparative analysis of the HUGO^TM robot‐assisted surgery system and the Da Vinci^® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment